未登录

张

张全英 (Zhang Quan-ying)

guangdong medical university

H指数:8

被引数:357

个人简介

任职于苏州大学附属第二医院，历任药剂科主任、药物临床试验机构副主任、机构办主任、I期临床试验研究室负责人。1985年毕业于中国药科大学药学系，获理学学士学位。研究方向包括新药I期临床研究、药物代谢动力学、生物利用度及生物等效性研究、基于popPK的个体化精准用药研究。近五年发表国内外学术论文60余篇，其中SCI论文10篇；连续多次主办省级及市级继续教育项目；获得发明专利1项。

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RETRACTION: Relationship between emotional intelligence and job well-being in Chinese clinical nurses: multiple mediating effects of empathy and communication satisfaction

临床护士情绪智力与工作幸福感的关系: 共情与沟通满意度的多重中介作用

IF3.9

2025-03-100

OAAI

The changes of multiparametric magnetic resonance imaging radiomics and Ki67 after two cycles of neoadjuvant therapy builds an early prediction model of pathological complete response in breast cancer

多参数磁共振成像放射组学及Ki67在两周期新辅助治疗后的变化，构建了乳腺癌病理完全缓解的早期预测模型

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Population pharmacokinetic/pharmacodynamic modeling of H018, a selective JAK1 inhibitor, in healthy Chinese volunteers

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2024-05-010

OA

MiRNA-296-5p promotes the sensitivity of nasopharyngeal carcinoma cells to cisplatin via targeted inhibition of STAT3/KLF4 signaling axis

SCIENTIFIC REPORTS

IF3.9

2024-03-204

OAAI

Construction of Z-scheme heterojunction LaCoO3 modified ZnO for photocatalytic degradation of tetracycline under visible light irradiation

CATALYSIS COMMUNICATIONS

IF4.3

2024-01-018

OAAI

MicroRNA-199a-3p suppresses the invasion and metastasis of nasopharyngeal carcinoma through SCD1/PTEN/AKT signaling pathway

CELLULAR SIGNALLING

IF3.7

2023-10-013

OA

Comparing the pharmacokinetics, safety, and immunogenicity of HLX02 to US- and EU-approved trastuzumab in healthy Chinese male subjects: A Phase I, randomized, double-blind, parallel-group study

EXPERT OPINION ON BIOLOGICAL THERAPY

IF4

2023-02-261

PRE

RETRACTED: Relationship between emotional intelligence and job well-being in Chinese clinical nurses: multiple mediating effects of empathy and communication satisfaction (Retracted article. See vol. 24, 2025)

IF3.9

2021-08-1315

OA

Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways

小檗碱通过激活苦味受体途径诱导GLP-1分泌

BIOCHEMICAL PHARMACOLOGY

IF5.6

2015-09-0186

PREAI

Jab1/Csn5: a new player driving the resistance to HER2-targeted therapies for breast cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2014-11-010

PREAI

Pharmacokinetics of levosulpiride after single and multiple intramuscular administrations in healthy Chinese volunteers

ACTA PHARMACEUTICA SINICA B

IF14.6

2014-10-018

OAAI

Jab1/CSN5 as a Novel Target to Overcome the Resistance to Trastuzurnab in Her2-positive Breast Cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2012-11-010

PREAI